Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
- PMID: 20058192
- DOI: 10.1245/s10434-009-0890-x
Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
Abstract
Background: Previous studies report that 5.9-22.2% of patients with preoperatively diagnosed early gastric cancers were eventually proven to have advanced gastric cancers by postoperative pathological examination. Such misdiagnosed cases commonly had cancers with macroscopic appearance like early gastric cancer and consequently can be recognized as a subgroup of cancer, namely advanced gastric cancer with early cancer macroscopic appearance (eAGC). Theoretically eAGCs might require D2 lymphadenectomy, but frequently undergo limited lymphadenectomy. However, the validity of the limited surgery is still unclear.
Methods: Clinicopathologic features of 134 patients with eAGC were retrospectively reviewed and compared with those of patients with early gastric cancers and advanced gastric cancers, respectively.
Results: Clinicopathologic features of eAGCs were similar to those of submucosa cancers, but significantly different from those of mucosa cancers and other muscularis propria cancers. Tumor size, lymphatic and/or blood vessels invasion (LBVI), and depth of invasion were identified as independent factors predicting lymph node metastasis; however, postoperative stage was not. All patients with eAGCs were proven to have lymph node metastasis restricted to the perigastric lymph nodes and lymph nodes at stations 7, 8a, and 9. Age, LBVI, and depth of invasion were independent prognostic factors for patients with preoperatively diagnosed early gastric cancers; however, the misdiagnosis of early cancer and the option of lymphadenectomy (D2 or not D2) had no impact on patient survival. The incidence of recurrence of eAGCs was similar to that of submucosa cancers, but significantly different from that of mucosa cancers and other muscularis propria cancers.
Conclusions: Modified gastrectomy B (dissection of perigastric lymph nodes and nodes at stations 7, 8a, and 9) might be recommended for patients with eAGCs.
Similar articles
-
Application of minimally invasive treatment for early gastric cancer.J Surg Oncol. 2004 Mar 15;85(4):181-5; discussion 186. doi: 10.1002/jso.20018. J Surg Oncol. 2004. PMID: 14991872
-
Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.Endoscopy. 2009 May;41(5):427-32. doi: 10.1055/s-0029-1214495. Epub 2009 May 5. Endoscopy. 2009. PMID: 19418397
-
Clinicopathological characteristics of stage 1 gastric cancer: comparison of macroscopic and microscopic findings.Hepatogastroenterology. 1997 Mar-Apr;44(14):554-8. Hepatogastroenterology. 1997. PMID: 9164536
-
Current status and future perspectives in gastric cancer management.Cancer Treat Rev. 2000 Aug;26(4):243-55. doi: 10.1053/ctrv.2000.0164. Cancer Treat Rev. 2000. PMID: 10913380 Review.
-
Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer.J Surg Oncol. 2005 Jul 1;91(1):90-4. doi: 10.1002/jso.20271. J Surg Oncol. 2005. PMID: 15999352 Review.
Cited by
-
Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matching.Surg Endosc. 2022 Feb;36(2):1456-1465. doi: 10.1007/s00464-021-08430-0. Epub 2021 Jun 3. Surg Endosc. 2022. PMID: 34085095 Free PMC article.
-
MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.Oncogene. 2012 Mar 15;31(11):1398-407. doi: 10.1038/onc.2011.340. Epub 2011 Aug 8. Oncogene. 2012. PMID: 21822301 Free PMC article.
-
Should the left gastric artery lymph node be considered as the predictive lymph node for extra-gastric lymph node metastases?Ann Transl Med. 2020 Jun;8(11):680. doi: 10.21037/atm-19-4786a. Ann Transl Med. 2020. PMID: 32617300 Free PMC article.
-
Diagnostic accuracy of the gastric cancer T-category with respect to tumor localization.Langenbecks Arch Surg. 2020 Sep;405(6):787-796. doi: 10.1007/s00423-020-01971-3. Epub 2020 Aug 26. Langenbecks Arch Surg. 2020. PMID: 32851434 Free PMC article.
-
Clinical Implication of Tumor-invasive Status into the Muscularis Propria in T2 Gastric Cancer.In Vivo. 2019 Jul-Aug;33(4):1341-1346. doi: 10.21873/invivo.11609. In Vivo. 2019. PMID: 31280228 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical